Allopurinol description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Allopurinol

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

ALLOPURINOL DESCRIPTION


Allopurinol


CLINICAL PHARMACOLOGY



Allopurinol






INDICATIONS AND USAGE).





INDICATIONS & USAGE


CLINICAL PHARMACOLOGY,CONTRAINDICATIONS,WARNINGS, andPRECAUTIONS).




ALLOPURINOL CONTRAINDICATIONS


WARNINGS


CLINICAL PHARMACOLOGY).



PRECAUTIONS

General







Information for Patients



Laboratory Tests

WARNINGS).



Drug Interactions
CLINICAL PHARMACOLOGY).









Drug/Laboratory Test Interactions


Pregnancy

Teratogenic Effects:





Nursing Mothers


Pediatric Use
INDICATIONS AND USAGE, andDOSAGE AND ADMINISTRATION).

ALLOPURINOL ADVERSE REACTIONS

PRECAUTIONSandDOSAGE AND ADMINISTRATION).
WARNINGS). Some patients with the most severe reaction also had fever, chills, arthralgias, cholestatic jaundice, eosinophilia and mild leukocytosis or leukopenia. Among 55 patients with gout treated with allopurinol for 3 to 34 months (average greater than 1 year) and followed prospectively, Rundles observed that 3% of patients developed a type of drug reaction which was predominantly a pruritic maculopapular skin eruption, sometimes scaly or exfoliative. However, with current usage, skin reactions have been observed less frequently than 1%. The explanation for this decrease is not obvious. The incidence of skin rash may be increased in the presence of renal insufficiency. The frequency of skin rash among patients receiving ampicillin or amoxicillin concurrently with allopurinol has been reported to be increased (seePRECAUTIONS).
Most Common Reactions* Probably Causally Related



ADVERSE REACTIONSintroduction,INDICATIONS AND USAGE,PRECAUTIONS, andDOSAGE AND ADMINISTRATION).
Incidence Less Than 1% Probably Causally Related









PRECAUTIONS)
Incidence Less Than 1% Causal Relationship Unknown











OVERDOSAGE





DOSAGE & ADMINISTRATION











HOW SUPPLIED





STORAGE AND HANDLING


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Allopurinol


Allopurinol

Allopurinol

ALLOPURINOL TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:52125-128(NDC:0603-2115)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ALLOPURINOL ALLOPURINOL 100 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
white 10 mm 2083;V ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:52125-128-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075798 2012-09-28


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.